Effects of rapamycin on cell growth and apoptosis of pancreatic carcinoma SW1990 cells
Hong Xia Yin, Yi Zhu, Yuling Wang, Yuan Gao
Abstract
Hong Xia Yin, Yi Zhu, Yuling Wang, Yuan Gao
Abstract
Objective: To investigate the effects of rapamycin on cell growth and apoptosis of pancreatic carcinoma SW1990 cells in vitro, and to elucidate its possible mechanism. Methods: MTT assay was used to detect the growth inhibitory rate of SW1990 cells treated with 5, 10, 20, 30, 40 and 50 nmol/L rapamycin for 24, 48 and 72 h, respectively. Cell apoptosis and cell cycle were detected by flow cytometry(FCM). The expressions of bcl-2, bcl-xL, bax and survivin were measured by Western blotting. Results: The inhibitory rate and apoptosis rate of SW1990 cells treated with rapamycin were higher than those in the negative control group (P<0.05), and with concentration-dependent and time-dependent effects. Compared with the control group, more cells in the rapamycin treatment group were arrested at G0 and G1 phases,while fewer cells were arrested at S, G2 and M phases (P<0.05) in a concentration-dependent manner. The expression of bax was increased, while the expressions of bcl-2, bcl-xL, survivin, bcl-xL/bax and bcl-2/bax were decreased (P<0.05) in SW1990 cells treated with 50 nmol/L rapamycin. Conclusion: Rapamycin can significantly inhibit the cell growth of SW1990 cells and also induce apoptosis. These effects are related with the expressions of bcl-2, bcl-xL, bax and survivin. DOI:10.3781/j.issn.1000-7431.2011.01.010
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate the effects of rapamycin on cell growth and apoptosis of pancreatic carcinoma SW1990 cells in vitro, and to elucidate its possible mechanism. Methods: MTT assay was used to detect the growth inhibitory rate of SW1990 cells treated with 5, 10, 20, 30, 40 and 50 nmol/L rapamycin for 24, 48 and 72 h, respectively. Cell apoptosis and cell cycle were detected by flow cytometry(FCM). The expressions of bcl-2, bcl-xL, bax and survivin were measured by Western blotting. Results: The inhibitory rate and apoptosis rate of SW1990 cells treated with rapamycin were higher than those in the negative control group (P<0.05), and with concentration-dependent and time-dependent effects. Compared with the control group, more cells in the rapamycin treatment group were arrested at G0 and G1 phases,while fewer cells were arrested at S, G2 and M phases (P<0.05) in a concentration-dependent manner. The expression of bax was increased, while the expressions of bcl-2, bcl-xL, survivin, bcl-xL/bax and bcl-2/bax were decreased (P<0.05) in SW1990 cells treated with 50 nmol/L rapamycin. Conclusion: Rapamycin can significantly inhibit the cell growth of SW1990 cells and also induce apoptosis. These effects are related with the expressions of bcl-2, bcl-xL, bax and survivin. DOI:10.3781/j.issn.1000-7431.2011.01.010
Key concepts: Survivin, Apoptosis, Flow cytometry, Biology, Cell growth, Cell cycle, Bcl-xL, Growth inhibition